As part of our continuing commitment to transplant recipients, we are always
looking for new and improved treatments, and novel approaches to help our patients optimize their health.
Drugs to prevent rejection and infection after the transplant
Long term strategies to help keep the recipient, live donor, and the transplanted organ as healthy as possible.
MOTP has participated in research for many years; both in major worldwide clinical trials, and in local investigator driven studies. The Clinical Trials Group was formally started in 1992 and is still going strong today.